Merck (26)

Browse by Contract Category

Contracts

Form of restricted stock unit terms for 2022 annual grants under the Merck & Co., Inc. 2019 Incentive Stock Plan (Filed With SEC on February 25, 2022)
2.900% Notes due 2061 Officers Certificate of the Company dated December 10, 2021, including form of the 2061 Notes (Filed With SEC on December 10, 2021)
Merck & Co., Inc. Deferral Program Including the Base Salary Deferral Plan (Amended and Restated effective December 1, 2019) (Filed With SEC on February 26, 2020)
Form of stock option terms for 2022 annual non-qualified option grants under the Merck & Co., Inc. 2019 Incentive Stock Plan (Filed With SEC on February 25, 2022)
Merck & Co., Inc. Plan for Deferred Payment of Directors Compensation (Amended and Restated effective as of January 1 (Filed With SEC on February 25, 2022)
2.750% Notes due 2051 Officers Certificate of the Company dated December 10, 2021, including form of the 2051 Notes (Filed With SEC on December 10, 2021)
2.150% Notes due 2031 Officers Certificate of the Company dated December 10, 2021, including form of the 2031 Notes (Filed With SEC on December 10, 2021)
1.900% Notes due 2028 Officers Certificate of the Company dated December 10, 2021, including form of the 2028 Notes (Filed With SEC on December 10, 2021)
1.700% Notes due 2027 Officers Certificate of the Company dated December 10, 2021, including form of the 2027 Notes (Filed With SEC on December 10, 2021)
Description of the Registrants 1.125% Notes due 2021, 1.875% Notes due 2026, and 2.500% Notes due 2034 (Filed With SEC on February 25, 2021)
Form of stock option terms for 2021 annual non-qualified option grants under the Merck & Co., Inc. 2019 Incentive Stock Plan (Filed With SEC on February 25, 2021)
Form of restricted stock unit terms for 2021 annual grants under the Merck & Co., Inc. 2019 Incentive Stock Plan (Filed With SEC on February 25, 2021)
Description of the Registrants 0.500% Notes due 2024 and 1.375% Notes due 2036 (Filed With SEC on February 25, 2021)
Description of the Registrants Common Stock (Filed With SEC on February 25, 2021)
2.450% Notes due 2050 Officers Certificate of the Company dated June 24, 2020, including form of the 2050 Notes (Filed With SEC on June 24, 2020)
2.350% Notes due 2040 Officers Certificate of the Company dated June 24, 2020, including form of the 2040 Notes (Filed With SEC on June 24, 2020)
1.450% Notes due 2030 Officers Certificate of the Company dated June 24, 2020, including form of the 2030 Notes (Filed With SEC on June 24, 2020)
0.750% Notes due 2026 Officers Certificate of the Company dated June 24, 2020, including form of the 2026 Notes (Filed With SEC on June 24, 2020)
Merck & Co., Inc. Plan for Deferred Payment of Directors Compensation (Amended and Restated effective as of January 1, 2020) (Filed With SEC on February 26, 2020)
4.000% Notes due 2049 Officers Certificate of the Company dated March 7, 2019, including form of the 2049 Notes (Filed With SEC on March 7, 2019)
3.900% Notes due 2039 Officers Certificate of the Company dated March 7, 2019, including form of the 2039 Notes (Filed With SEC on March 7, 2019)
3.400% Notes due 2029 Officers Certificate of the Company dated March 7, 2019, including form of the 2029 Notes (Filed With SEC on March 7, 2019)
2.900% Notes due 2024 Officers Certificate of the Company dated March 7, 2019, including form of the 2024 Notes (Filed With SEC on March 7, 2019)
Severance Agreement and General Release between Merck & Co., Inc. and Adam H. Schechter, dated December 1, 2018 (Filed With SEC on February 27, 2019)
Offer Letter between Merck & Co., Inc. and Jennifer Zachary, dated March 16, 2018 (Filed With SEC on February 27, 2019)
Merck & Co., Inc. U.S. Separation Benefits Plan (amended and restated as of January 1, 2019) (Filed With SEC on February 27, 2019)